Key Medicine Shortages for May 2022
Key Medicine Shortages – May 2022
Posted: Friday, May 6, 2022
Category - Medicines Update
GGC Medicines Update is a series of blogs with important medicines related messages relevant to all healthcare professionals across GGC.
Please note, Medicines Update blogs are correct at the time of publication.
Medicines Update blogs remain on the website for 4 years. If you would like a copy of a blog published more than 4 years ago, please contact ggc.medicines.update@nhs.scot.
Click here for a promotional poster on Medicines Update and here for an animation on the Communications subcommittee of ADTC responsible for the development of Medicines Update.
If you would like to contribute to Medicines Update, click here for a guide to blog writing. When you email the committee to discuss writing a blog, you will be sent a checklist to complete prior to submitting the blog for review.
Posted: Friday, May 6, 2022
Category - Medicines Update
Key Medicine Shortages for May 2022
Posted: Friday, May 6, 2022
Category - Medicines Update
Guideline News for April 2022
Posted: Friday, April 29, 2022
Category - Medicines Update
The NHSGGC management of generalised convulsive status epilepticus in adults guideline has been updated.
Key changes
Posted: Wednesday, April 27, 2022
Category - Medicines Update
All healthcare professionals involved in patient care have a responsibility to report suspected ADRs
Posted: Friday, April 22, 2022
Category - Medicines Update
Opioid choice
Patient factors
Indication
Observe
Independent check
Dose equivalence
Storage
Posted: Wednesday, April 20, 2022
Category - Medicines Update
MHRA Drug Safety Update for April 2022
Posted: Friday, April 15, 2022
Category - Medicines Update
Key messages: Lithium is a gold standard treatment for maintenance treatment of bipolar affective disorder Lithium has a high potential for toxicity and requires careful monitoring to ensure its safe and...
Posted: Friday, April 15, 2022
Category - Medicines Update
Key points SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin noradrenaline reuptake inhibitors) are associated with a risk of bleeding, especially upper GI bleedingThe risk of GI bleeding ...
Posted: Monday, April 11, 2022
Category - Medicines Update
Posted: Friday, April 1, 2022
Category - Medicines Update
MHRA Drug Safety Update for March 2022